NFE2L2 and chronic obstructive pulmonary disease: Therefore, in the current study we investigated whether NFE2L2 or KEAP1 polymorphisms affect the level and longitudinal course of FEV1 (Forced Expiratory Volume in 1 second), both being important risks for COPD [24].